Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation. (Record no. 16626619)

MARC details
000 -LEADER
fixed length control field 01575 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515043917.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0887-6924
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/sj.leu.2404435
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Karlsson, C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070920
245 00 - TITLE STATEMENT
Title Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia
Date of publication, distribution, etc. Dec 2006
300 ## - PHYSICAL DESCRIPTION
Extent 2204-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Alemtuzumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Neoplasm
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infections
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Lymphocytic, Chronic, B-Cell
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Norin, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kimby, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sander, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Porwit Macdonald, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nilsson, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Johansson, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mellstedt, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lundin, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Osterborg, A
773 0# - HOST ITEM ENTRY
Title Leukemia
Related parts vol. 20
-- no. 12
-- p. 2204-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/sj.leu.2404435">https://doi.org/10.1038/sj.leu.2404435</a>
Public note Available from publisher's website

No items available.